James V Alvarez

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Breast Cancer Risk

Tyrosine Kinase

Top Venues

Science advances

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Enakshi D Sunassee, Riley J Deutsch, Victoria W D'Agostino, Pol Castellano-Escuder, Elizabeth A Siebeneck, Olga R Ilkayeva, Brian T Crouch, Megan C Madonna, Jeffrey I Everitt, James V Alvarez, Gregory M Palmer, Matthew D Hirschey, Nirmala Ramanujam
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence. Science advances 10 (14) (2024)
Enakshi D Sunassee, Riley J Deutsch, Victoria W D'Agostino, Pol Castellano-Escuder, Elizabeth A Siebeneck, Olga R Ilkayeva, Brian T Crouch, Megan C Madonna, Jeffrey I Everitt, James V Alvarez, Gregory M Palmer, Matthew D Hirschey, Nirmala Ramanujam
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence. Science advances 10 (14) (2024)
Enakshi D Sunassee, Riley J Deutsch, Victoria W D'Agostino, Pol Castellano-Escuder, Elizabeth A Siebeneck, Olga R Ilkayeva, Brian T Crouch, Megan C Madonna, Jeffrey I Everitt, James V Alvarez, Gregory M Palmer, Matthew D Hirschey, Nirmala Ramanujam
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence. Science advances 10 (14) (2024)
Enakshi D Sunassee, Riley J Deutsch, Victoria W D'Agostino, Pol Castellano-Escuder, Elizabeth A Siebeneck, Olga R Ilkayeva, Brian T Crouch, Megan C Madonna, Jeffrey I Everitt, James V Alvarez, Gregory M Palmer, Matthew D Hirschey, Nirmala Ramanujam
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence. Science advances 10 (14) (2024)
Nina Marie G Garcia, Jessica N Becerra, Brock J McKinney, Ashley V DiMarco, Feinan Wu, Matthew Fitzgibbon, James V Alvarez
APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer. bioRxiv : the preprint server for biology (2023)
Ashley V DiMarco, Xiaodi Qin, Brock J McKinney, Nina Marie G Garcia, Sarah C Van Alsten, Elizabeth A Mendes, Jeremy Force, Brent A Hanks, Melissa A Troester, Kouros Owzar, Jichun Xie, James V Alvarez
APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses. Cancer immunology research (2021)
Chao-Chieh Lin, Wen-Hsuan Yang, Yi-Tzu Lin, Xiaohu Tang, Po-Han Chen, Chien-Kuang Cornelia Ding, Dan Chen Qu, James V Alvarez, Jen-Tsan Ashley Chi
DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. Oncogene 40 (11) (2021)
Douglas B Fox, Nina Marie G Garcia, Brock J McKinney, Ryan Lupo, Laura C Noteware, Rachel Newcomb, Juan Liu, Jason W Locasale, Matthew D Hirschey, James V Alvarez
NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism. Nature metabolism 2 (4) (2020)
Andrea Walens, Jiaxing Lin, Jeffrey S Damrauer, Brock McKinney, Ryan Lupo, Rachel Newcomb, Douglas B Fox, Nathaniel W Mabe, Jeremy Gresham, Zhecheng Sheng, Alexander B Sibley, Tristan De Buysscher, Hemant Kelkar, Piotr A Mieczkowski, Kouros Owzar, James V Alvarez
Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence. Nature communications 11 (1) (2020)
Andrea Walens, Ashley V DiMarco, Ryan Lupo, Benjamin R Kroger, Jeffrey S Damrauer, James V Alvarez
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors. eLife 8 (2019)
Megan C Madonna, Douglas B Fox, Brian T Crouch, Jihong Lee, Caigang Zhu, Amy F Martinez, James V Alvarez, Nirmala Ramanujam
Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes. Molecular cancer research : MCR 17 (7) (2019)